Note: The Prescribing Information revised 10/2026 lists the prefilled single-dose syringe; the Repatha HCP site, as captured on November 13, 2026, states that Amgen planned to discontinue it by Q1 2026. The site's discontinuation notice describes two device presentations (the SureClick autoinjector and the prefilled syringe) and does not mention the prefilled single-dose pen.